Alliancebernstein L.P. Ambrx Biopharma Inc. Transaction History

Alliancebernstein L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.3 - $16.6 $439,852 - $785,113	47,296 New	47,296 $543,000
Q3 2021 Nov 10, 2021	SELL	$13.31 - $22.53 $931,700 - $1.58 Million	-70,000 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$15.95 - $19.6 $1.12 Million - $1.37 Million	70,000 New	70,000 $1.37 Million

31.2K

Ticker AMAM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,618,400
Market Cap $1.08B
Description
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.